Natural history, treatment (tx) patterns, and outcomes in MET dysregulated non-small cell lung cancer (NSCLC) patients (pts)

被引：0
|
作者：
Wolf, J. [1 ]
Baik, C. [2 ]
Heist, R. S. [3 ]
Neal, J. W. [4 ]
Mansfield, A. S. [5 ]
Buettner, R. [6 ]
Davis, K. L. [7 ]
Giovannini, M. [8 ]
Mutebi, A. [9 ]
Awad, M. M. [10 ]
机构：
[1] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany
[2] Univ Washington, Thorac Head & Neck Med Oncol, Seattle, WA 98195 USA
[3] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
[4] Stanford Univ, Dept Med, Div Oncol, Stanford Canc Inst, Stanford, CA 94305 USA
[5] Mayo Clin, Med Oncol, Rochester, MN USA
[6] Univ Hosp Cologne, Inst Pathol, Cologne, Germany
[7] RTI Hlth Solut, Hlth Econ, Res Triangle Pk, NC USA
[8] Novartis Pharmaceut, Global Clin Dev, E Hanover, NJ USA
[9] Novartis Pharmaceut, US Hlth Econ & Outcomes Res, E Hanover, NJ USA
[10] Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
403 (PB-06
引用
收藏
页码：E131 / E131
页数：1
相关论文
共 50 条
  • [21] CRIZOTINIB TREATMENT IN PATIENTS (PTS) WITH ADVANCED ROS1-REARRANGED NON-SMALL CELL LUNG CANCER (NSCLC)
    Ou, S. -H. I.
    Kim, D. -W.
    Camidge, R.
    Riely, G. J.
    Salgia, R.
    Shapiro, G.
    Clark, J. W.
    Tye, L.
    Iafrate, A. J.
    Shaw, A.
    ANNALS OF ONCOLOGY, 2013, 24
  • [22] Stage IIIA Non-Small Cell Lung Cancer (NSCLC): Outcomes by Treatment Strategy
    Carroway, W. P.
    Jiang, S-F.
    Velotta, J.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S588 - S589
  • [23] Clinical management patterns and treatment outcomes in patients with non-small cell lung cancer (NSCLC) across Europe: EPICLIN-Lung study
    Carrato, A.
    Vergnenegre, A.
    Thomas, M.
    McBride, K.
    Medina, J.
    Cruciani, G.
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (03) : 447 - 461
  • [24] The cost of non-small cell lung cancer (NSCLC) treatment
    Vergnenegre, A.
    ONCOLOGIE, 2012, 14 (05) : 310 - 315
  • [25] Cobolimab With Dostarlimab and Docetaxel in Patients (pts) With Advanced Non-small Cell Lung Cancer (NSCLC): COSTAR Lung
    Kim, Hye Ryun
    Gridelli, Cesare
    Kapur, Dinesh
    Tufman, Amanda
    Felip, Enriqueta
    Velcheti, Vamsidhar
    Kim, Yu Jung
    Goetze, Thorsten
    Lopez, Pilar Garrido
    Corre, Romain
    Penkov, Konstantin
    Anjum, Rana
    Di Pace, Brian
    Liu, Wenlei
    Borgovan, Theo
    Ledger, Danielle
    Carver, Jennifer
    Waszak, Angela
    Dhar, Arindam
    Novello, Silvia
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 163 - 163
  • [26] Prognostic implication of smoking history in patients with non-small cell lung cancer (NSCLC)
    Oze, I.
    Segawa, Y.
    Nogami, N.
    Komori, E.
    Sawada, S.
    Yamashita, M.
    Shinkai, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [27] TREATMENT PATTERNS IN A COHORT OF ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS (PTS) TREATED IN THE COMMUNITY SETTING
    Corral, Mitra
    Nadler, Eric S.
    Chen, Clara
    Forsyth, Michael
    Penrod, John R.
    Salvati, Mark E.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S521 - S522
  • [28] NRAS mutated non-small cell lung cancer (NSCLC) patients: Characteristics and outcomes
    Dehem, A.
    Mazieres, J.
    Chour, A.
    Guisier, F.
    Ferreira, M.
    Boussageon, M.
    Girard, N.
    Moro-Sibilot, D.
    Cadranel, J.
    Zalcman, G.
    Ricordel, C.
    Wislez, M.
    Munck, C.
    Poulet, C-H.
    Gauvain, C.
    Descarpentries, C.
    Wasielewski, E.
    Cortot, A. B.
    Baldacci, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S1023 - S1024
  • [29] Reporting of patient reported outcomes in randomized clinical trials (RCTs) in non-small cell lung cancer (NSCLC) patients (pts)
    Palmeri, Laura
    Derkach, Sergii
    Mazur-Janik, Ewelina
    Soman, Arundhati
    Alves, Catarina Ribeiro
    Shah, Radhika
    Vidal-Fisher, Liat
    Shahmarvand, Nahid
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [30] Impact of MET inhibitors on survival among patients (pts) with MET exon 14 mutant (METdel14) non-small cell lung cancer (NSCLC).
    Awad, Mark M.
    Leonardi, Giulia Costanza
    Kravets, Sasha
    Dahlberg, Suzanne Eleanor
    Drilon, Alexander E.
    Noonan, Sinead
    Camidge, D. Ross
    Ou, Sal-Hong Ignatius
    Costa, Daniel Botelho
    Gadgeel, Shirish M.
    Steuer, Conor Ernst
    Forde, Patrick M.
    Zhu, Viola Weijia
    Fukuda, Yoko Korenaga
    Clark, Jeffrey W.
    Janne, Pasi A.
    Mok, Tony
    Sholl, Lynette M.
    Heist, Rebecca Suk
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345